LINDA BAER: Open Payments
NPI 1083963383 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,902 in 15 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $56 · 2025 $3,902
Consulting: $3,000Food & beverage: $495Travel & lodging: $407
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 10 | $3,787 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Genentech USA, Inc. | 1 | $32 |
| GENZYME CORPORATION | 1 | $26 |
| Janssen Scientific Affairs, LLC | 1 | $23 |
Products named: Niktimvo, Columvi, JAKAFI, TECVAYLI, NINLARO, ICLUSIG.
Industry payments across OH — which companies pay providers there.
